Thank you
Thank you for participating in today's webinar.
Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming
for the future.
Description
Boehringer Ingelheim is pleased to
bring you a stimulating discussion featuring a panel of experts: Brad Drummond,
MD, and Mike Hess RT.
These panelists will review:
- What have we learned about COPD management and how can we stay informed amidst the COVID-19 pandemic?
- How does real-world evidence (RWE) enhance our knowledge on the prevalence of suboptimal peak inspiratory flow (PIF) in COPD?
In addition, these panelists will review:
- Did real world evidence show an association between inhaler choice and exacerbation frequency, and readmissions in the treatment of COPD?
This program is sponsored by Boehringer Ingelheim.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CEU's or credits are provided for this webinar.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.